Richard S Levy Insider Trading $INCY INCYTE CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard S Levy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard S Levy. Richard S Levy is EVP, Chief Drug Dev&Medical Of in INCYTE CORP ($INCY).
Richard S Levy in INCYTE CORP
Trading Symbol: INCYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Richard S Levy: EVP, Chief Drug Dev&Medical Of
Holdings: 18,205 shares
Current Value: $2,151,467
Latest Transaction: Feb 18 2015
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Richard S Levy in INCYTE CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 18 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 8,317 | 122,426 | 0 | |
Feb 18 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 17.79 | 3,683 | 65,521 | 90,217 | |
Feb 18 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 76.90 | 12,000 | 922,800 | 18,205 | 30.2 K to 18.2 K (-39.73 %) |
Feb 18 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 8,317 | 122,426 | 30,205 | 21.9 K to 30.2 K (+38.00 %) |
Feb 18 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 17.79 | 3,683 | 65,521 | 21,888 | 18.2 K to 21.9 K (+20.23 %) |
Feb 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 25,000 | 458,000 | 91,782 | |
Feb 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 75.11 | 25,000 | 1,877,750 | 18,205 | 43.2 K to 18.2 K (-57.86 %) |
Feb 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 25,000 | 458,000 | 43,205 | 18.2 K to 43.2 K (+137.32 %) |
Jan 20 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 12,000 | 176,640 | 8,317 | |
Jan 20 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 73.07 | 12,000 | 876,840 | 18,205 | 30.2 K to 18.2 K (-39.73 %) |
Jan 20 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 12,000 | 176,640 | 30,205 | 18.2 K to 30.2 K (+65.92 %) |
Jan 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 73.21 | 1,085 | 79,433 | 1,085 | |
Jan 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 73.21 | 20,460 | 1,497,877 | 20,460 | |
Jan 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Grant | A | 0.00 | 3,022 | 0 | 21,227 | 18.2 K to 21.2 K (+16.60 %) |
Jan 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 25,000 | 458,000 | 116,782 | |
Jan 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 71.84 | 25,000 | 1,796,000 | 18,205 | 43.2 K to 18.2 K (-57.86 %) |
Jan 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 25,000 | 458,000 | 43,205 | 18.2 K to 43.2 K (+137.32 %) |
Dec 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 12,000 | 176,640 | 20,317 | |
Dec 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 72.36 | 12,000 | 868,320 | 18,205 | 30.2 K to 18.2 K (-39.73 %) |
Dec 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 12,000 | 176,640 | 30,205 | 18.2 K to 30.2 K (+65.92 %) |
Nov 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 12,000 | 176,640 | 32,317 | |
Nov 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 69.97 | 12,000 | 839,640 | 18,205 | 30.2 K to 18.2 K (-39.73 %) |
Nov 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 12,000 | 176,640 | 30,205 | 18.2 K to 30.2 K (+65.92 %) |
Page: 1